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been trying to control. There has been a great deal of advancement to limit pain caused by surgery, from the
anesthesia during surgery to the commonly used opioids after surgery. Preemptive analgesia is defined as an
anti-nociceptive treatment that prevents establishment of altered processing of afferent input, which can
increase postoperative pain. By reducing the level of prostaglandins in your body, NSAIDs help relieve pain
any condition causing inflammation, fever, and also prevent clotting. For these reasons it is felt that the use of
NSAIDS preemptively could be helpful in decreasing the sensation of pain before it starts. With the
discomfort of surgery kept to a minimum, pain medications could be decreased. With the decrease of
analgesic medication also comes the decrease of unwanted side effects the worst of these being, opioid
addiction or dependancy. Methods: This systematic review examines original research that looks at the
preemptive use of NSAIDS in orthopedic surgery and the effects on postoperative pain. There were many
articles excluded for their use of vioxx, some that were older and all those that had Dr. Scott Reuben as an
author due to fabricated data. Results: Three studies published in the last ten years comparing the use of
NSAIDs to placebo and one observationally blinded study during orthopedic surgery where included. These
four studies looked at the preemptive use of NSAIDs in orthopedic surgery and either compared it to placebo
or no intervention. The articles found did look at postoperative pain and analgesic usage. Conclusion: Non-
Steroidal Anti-Inflammatory Drugs have been shown to have a greater postoperative effect on pain relief when
given preemptively to those undergoing orthopedic surgery, than currently used postoperative practices.
Opioid sparing is possible with preemptive use of NSAIDs, but were NSAIDs to be used every 12 hours after
surgery further opioid sparing could be possible as discussed in the Haung et al study.
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B iogr aphy 
Jesse Mumm grew up in Rexburg, ID where he also graduated with his bachelors in 
Health Science.  Jesse had always wanted to be a doctor but did not want to put all that 
time into school, so when he heard of the Physician Assistant profession he new it would 
be a perfect fit.  Jesse has always wanted to be able to have a family of his own with 
whom to have fun, and to spend a lot of time, and being a PA would allow him that life 
style.   While going to college Jesse worked full-time as a construction worker, small 
engine mechanic, and phlebotomist.  After graduating with a bachelors he was employed 
at a surgery center that offered him a wide range of experience.  While at the surgery 
center Jesse was the x-ray technician, phlebotomist, did laundry, building maintenance, 
purchased medical supplies, was able scrub in on a number of surgeries, performed EKGs 
and cleared all patients for surgery.  During all this Jesse has been able to start his family, 
he currently has a 7, 4 and 3 year old boys and a little girl that is one and is expecting 
baby  number five soon after graduating PA school.  
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AB ST R AC T  
B ackgr ound: Pain and infection are two of the major unwanted outcomes of surgery that 
physician have long been trying to control.  There has been a great deal of advancement 
to limit pain caused by surgery, from the anesthesia during surgery to the commonly used 
opioids after surgery.  Preemptive analgesia is defined as an anti-nociceptive treatment 
that prevents establishment of altered processing of afferent input, which can increase 
postoperative pain. By reducing the level of prostaglandins in your body, NSAIDs help 
relieve pain any condition causing inflammation, fever, and also prevent clotting.  For 
these reasons it is felt that the use of NSAIDS preemptively could be helpful in 
decreasing the sensation of pain before it starts. With the discomfort of surgery kept to a 
minimum, pain medications could be decreased.  With the decrease of analgesic 
medication also comes the decrease of unwanted side effects the worst of these being, 
opioid addiction or dependancy. 
M ethods: This systematic review examines original research that looks at the preemptive 
use of NSAIDS in orthopedic surgery and the effects on postoperative pain.  There were  
many articles excluded for their use of vioxx, some that were older and all those that had 
Dr. Scott Reuben as an author due to fabricated data. 
R esults:  Three studies published in the last ten years comparing the use of NSAIDs to 
placebo and one observationally blinded study during orthopedic surgery where included. 
These four studies looked at the preemptive use of  NSAIDs in orthopedic surgery and 
either compared it to placebo or no intervention.  The articles found did look at 
postoperative pain and analgesic usage.  
C onclusion:  Non-Steroidal Anti-Inflammatory Drugs have been shown to have a greater 
postoperative effect on pain relief when given preemptively to those undergoing 
orthopedic surgery, than currently used postoperative practices.  Opioid sparing is 
possible with preemptive use of NSAIDs, but were NSAIDs to be used every 12 hours 
after surgery further opioid sparing could be possible as discussed in the Haung et al 
study. 
K eywor ds:  preemptive NSAIDs, opioid sparing, orthopedic surgery and pain relief  
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A B B R E V I A T I ONS 
 
NSAIDS........................................ Non-steroidal anti-inflammatory drugs 
VAS............................................... Visual Analog Score 
COX.............................................. Cyclooxygenase 
PGE2............................................. Prostaglandin E2 
IV................................................... Intravenous 
PCA............................................... Patient-Controlled Analgesia 
TKA............................................... Total Knee Arthroplasty 
ROM.............................................. Range of Motin 
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Pr eemptive Non-Ster oidal A nti-I nflammator y Dr ugs for  Or thopedic Sur ger y 
 
B A C K G R OUND 
 Pain and infection are two of the major unwanted outcomes of surgery that 
physicians have long been trying to control.  There has been a great deal of advancement 
to limit pain caused by surgery, from the anesthesia during surgery to the commonly used 
opioids after surgery.  Medications have also been given before surgery to decrease 
discomfort this is termed preemptive analgesia. Preemptive analgesia is defined as an 
antinociceptive treatment that prevents establishment of altered processing of afferent 
input, which can increase postoperative pain. The concept of preemptive analgesia has 
been around since the last century, when Crile advocated the use of regional blocks in 
combination with general anesthesia to prevent intraoperative nociception and the 
formation of painful scars resulting from surgery.1  Whether preemptive analgesic 
interventions are more effective than current method of controlling acute postoperative 
pain remains controversial.  A meta-analysis reviewed several studies that addressed this 
question and have drawn fundamentally different conclusions.2  Some of the studies 
looked at concluded that preemptive analgesia is effective as such, but some have 
concluded it to be effective only for certain analgesic drugs and surgeries.2  Some 
analyses have attributed no beneficial effect to any drug, whereas some have postulated 
dependence on a range of factors, and some reviews have been unable to draw a final 
conclusion regarding efficacy.2   This systematic review will look at the preemptive use of 
non-steroidal anti-inflammatory drugs (NSAIDs) in orthopedic surgery to decrease 
postoperative pain and the use of opioids.   
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 Non-steroidal anti-inflammatory drugs (NSAIDs) stop cyclooxygenase enzymes 
(COX enzymes) in our bodies from working. COX enzymes increase production of 
hormone-like substances called prostaglandins, which can cause the feeling of pain by 
irritating nerve endings.3  When nociceptors are activated by the noxious stimuli caused 
by tissue damage or infection, chemical substances and enzymes are released from the 
damaged tissues, increase the transduction of painful stimuli. Prostaglandins and 
leukotrienes cause sensitization of the peripheral receptors, reducing their activation 
threshold and increasing their responsiveness to stimuli.4  By reducing the level of 
prostaglandins in your body, NSAIDs help relieve pain any condition causing 
inflammation, fever, and also prevent clotting.3   For these reasons it is felt that the use of 
NSAIDS preemptively could be helpful in decreasing the sensation of pain before it 
starts. With the discomfort of surgery kept to a minimum, pain medications could be 
decreased.  With the decrease of analgesic medication also comes the decrease of 
unwanted side effects the worst of these being, opioid addiction or dependency. 
 
M E T H ODS 
 This systematic review examines original research that looks at the preemptive use 
of NSAIDS in orthopedic surgery and the effects on postoperative pain.  Meta-analyses 
and narrative reports are only used for background information.  A search of the literature 
published in the previous ten years was conducted on the MEDLINE, CINAHL, and Web 
of Science databases using the following search terms: Preoperative, preemptive, 
postoperative pain, NSAIDs, orthopedic surgery and surgery. Subsequent examination of 
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bibliographic entries in retrieved works yielded additional studies for consideration.  All 
studies were reviewed and scored as shown in Table 1. 
 The search was then limited to the English publications and adult subjects. All 
studies used, had a focus on preemptive use of current FDA approved non-steroidal anti-
inflammatory drugs in orthopedic surgery.  This was done to eliminate those studies that 
used Vioxx (rofecoxib) and other cycloxygenase-2 (COX-2) that are not approved due to 
the COX-2  adverse drug reactions. Also excluded several articles with Dr. Scott Reuben 
as an author as the journal of Anesthesia and Analgesia states that Dr. Scott Reuben 
fabricated data reported, and that all fabricated data were created under the sole control of 
Dr. Reuben.5    
 
R E SUL T S 
 Three studies published in the last ten years comparing the use of NSAIDs to 
placebo and one observationally blinded study during orthopedic surgery where 
included.6-9  These four studies looked at the preemptive use of  NSAIDs in orthopedic 
surgery and either compared it to placebo or no intervention.   
 
 
 
T akada et al, 2007 
 Takada et al6  set a goal to clarify the effects of pre-administration of flurbiprofen, a 
nonselective cycloxygenase (COX) inhibitor, on plasma concentrations of prostaglandin 
E2 (PGE2) in patients undergoing open knee surgery using a tourniquet.  Nonsteroidal 
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anti-inflammatory drugs (NSAIDs) inhibit the synthesis of PGs both in the spinal cord 
and at the periphery.  This study also looks at the preemptive effects of flurbiprofen on 
post operative pain and opioid use.6 
 The study was performed in a prospective, randomized, controlled, and double-
blind fashion.  All solutions were prepared in a 100-mL bag of saline by the first 
investigator who was also responsible for subject grouping. The second investigator that 
performed IV injections was blinded as to type of test solution.  The outcomes were 
measured by a third investigator who was blinded as to the type of solution.6 
 The study states that subjects were randomly divided, by sealed envelope 
assignment, into two groups. Group A (n = 16) received one mLd kg1 intralipid as a 
placebo, and group B (n = 16) received one mgd kg1 (1 mLd kg1) flurbiprofen IV 6 
minutes before tourniquet inflation.6  Placebo and flurbiprofen were administered over 16 
minutes, and completed 6 minutes before the tourniquet inflated. Both solutions were 
made to be similar in appearance.6 
 Six mL of blood was taken from the femoral vein and cubital vein to measure 
plasma concentrations of PGE2.  Blood samples were taken before tourniquet inflation 
(T1; before the administration of IV drugs), before tourniquet deflation (T2), and 
immediately after tourniquet deflation (T3).6(Table 2) 
 Postoperative analgesia was supplied by IV 0.1 mg buprenorphine according to 
patient demand. The postoperative pain was assessed at 0.5, one, two, 4, 6, 12 and 24 
hours after surgery, using a Visual Analog Scale (VAS), by trained nurses that were 
blinded as to which patients had received preemptive NSAIDs.  All side effects were 
recorded as reported by patients or by nurse observation.6 
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 The visual analog scale (VAS) in the experimental group B was significantly lower 
than group A at 0.6( P = 0.0033), one ( P = 0.0018), two ( P = 0.0038), and 4 ( P = 
0.0424) hours after surgery.  By 6 hours post surgery, the differences in VAS scores were 
no longer significant.  Buprenorphine consumption in group B was also significantly 
lower than that in group A during the first 4 post operative hours(P<.01 vs. group A). In 
group A, plasma concentrations of PGE2 in the femoral vein increased significantly at T2 
and returned to control values (T1 level) at T3, whereas PGE2 in the cubital vein showed 
little change throughout the time course.(Table 2)  In group B, plasma concentrations of 
PGE2 in either the femoral or cubital vein showed no change through time.(Table 2)  
There were no adverse effects associated with flurbiprofen in this study.6 
 
Nor man et al 
 Norman et al7 performed a randomized, double-blind, controlled trial, set out to 
examine the effect of ketorolac as a preemptive analgesic for limited orthopedic surgery 
of the lower extremity, performed with a tourniquet. The preemptive dose was 
administered shortly before the tourniquet was inﬂated, and the postoperative dose was 
administered immediately after tourniquet inﬂation. Because ketorolac exerts its 
analgesic effects primarily at the peripheral level, the second dose functions as a 
poststimulus dose, because it does not reach the surgery site until after the tourniquet is 
deﬂated at the end of surgery.  This study has a unique model for exploring the potential 
effects of preemptive analgesia by NSAIDs without having the problem of a time delay 
between the administration of the poststimulus doses of analgesia.7  
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 Patients were randomly assigned by a computer generated table of random numbers 
to receive ketorolac before (PRE group), or after (POST group), tourniquet inﬂation.  
Each subject received one 50-ml bag of 0.9% NaCl intravenously after induction, while 
the leg was being prepared, and a second 50-ml bag of 0.9% NaCl intravenously 
immediately after tourniquet inﬂation. The time interval between administration of these 
bags was less than 16 minutes.  Patients in the PRE group received ketorolac before 
tourniquet inﬂation and placebo after tourniquet inﬂation, and the POST group received 
its placebo first, and ketoralac after tourniquet inflation. Double-blinding was achieved 
by having the hospital pharmacy prepare the 50-ml bags for each patient and label them 
with only the patient’s identiﬁcation number. The pharmacy retained the codes which 
indicated to what group the patients were assigned, until the conclusion of the study.7 
 Norman et al7 reported that postoperative analgesia was supplied by intravenous 
morphine using patient-controlled analgesia (PCA) with a 2-mg bolus dose, lockout 
period of 10 minutes, 4-hour maximum dose of 28 mg, and no basal infusion rate.7 
 Patients’ visual analog scale (VAS) pain scores were documented thirty minutes 
preoperatively by each subject as a base.  The VAS was a 100-mm scale, were patients 
were instructed that a 100 signified  the “worst possible pain” and 0 represented “no 
pain”.   VAS scores, cumulative PCA morphine usage and presence or absence of 
bleeding at the surgical site was recorded postoperatively at 2,4,6,8,10,12 and 24 hours 
after tourniquet inﬂation.  The study calculated the sample size by assuming that a 30% 
reduction in pain scores or postoperative morphine usage would be clinically useful.7 
 Furthermore, the study reported that the demographic data for both groups were 
similar.  Of the 54 subjects enrolled in the study, 6 were eliminated from the study: 2 in 
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the PRE group (one because of malfunction of the tourniquet, and one because of an 
inadvertent booking of a midfoot fracture as an ankle fracture) and 4 in the POST group 
(one because of conversion of the surgical procedure to a closed reduction, one because 
of administration of intravenous fentanyl in the postoperative anesthesia care unit, one 
because of incorrect timing of study drug administration, and one because of an 
administrative error).   The ﬁnal PRE group consisted of 23 subjects, and the POST group 
was composed of 26 subjects.  Graphic analysis of  VAS scores revealed that any 
postoperative differences were present from 2– 4 hours only.  Norman et al7 stated that 
“VAS pain scores were signiﬁcant for PRE versus POST at P = 0.0226 and were 
signiﬁcant for change over time at P = 0.00158. The PRE group had signiﬁcantly lower 
VAS pain scores than the POST group at hour 2 (P = 0.0203) and hour 4 (P= 0.00549). 
By hour 6, the intergroup differences were not signiﬁcant (P = 0.388).”7  Although VAS 
scores were lower in the PRE group morphine usage was similar for both groups.7  
 
 
 
T akada et al, 2009 
 Takada et al8 looked at the preemptive effects of flurbiprofen in arthroscopic rotator 
cuff repair. The study hypothesized that the combination of intravenous ﬂurbiprofen and 
the currently used intraarticular ropivacaine could produce better postoperative analgesia 
than intraarticular ropivacaine alone, because the two drugs have different sites of   
action.8 
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 Each patient was preoperatively instructed in the use of a 100-mm horizontal visual 
analog scale (VAS) for the evaluation of postoperative pain. The study was performed in 
a prospective, randomized, placebo controlled and double-blind fashion by three 
investigators.  The first investigator prepared the 100-ml bag of saline, and was 
responsible for subject grouping. The second investigator who performed the intravenous 
injection, did not know the type of test solution being used.  The postoperative VAS 
scores were recorded by the third investigator, who was blinded to the type of test 
solution used.8 
 Patients were placed randomly in to two equally sized groups by the use of a table 
of random numbers. Group A (n = 22) received 0.1 ml/kg lipid emulsion, in which the 
ingredients are the same as those of the ﬂurbiprofen solvent, as a placebo, given 
intravenously 6 minutes before surgery. This was done to keep the two solutions similar 
in appearance.  Group B (n = 22) received 1 mg/kg ﬂurbiprofen, given intravenously 6 
minutes before surgery. The placebo and ﬂurbiprofen were mixed with 100 ml saline and 
given over a period of 16 minutes.8 
 VAS scores were assessed and recorded at 0.5, 1, 2, 4, 6, 12 and 24 hours after 
surgery. Postoperative analgesia was provided with intravenous 0.1 mg buprenorphine 
was given according to patient demand.  The time was also measured from directly after 
surgery to the time when first dose of buprenorpine was given.8 
  This study reported  that the demographic data for both groups were similar . VAS 
scores in group B were signiﬁcantly lower than those in group A within the ﬁrst 6 hours 
postoperatively (Table 5), but no signiﬁcant difference was found in VAS scores at 12 
hours or later.  Buprenorphine consumption in group B was also signiﬁcantly lower than 
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that in group A within the ﬁrst 2 hours postoperatively , but from 4 hours and later no 
difference was measured.(Table 4)  The time to the ﬁrst analgesic was given in group B 
(368 ± 296 min) was signiﬁcantly longer (P = 0.0027) than that in group A (110 ± 167 
min).  
 
H uang et al 
 The purpose of the Huang et al study9 was to show the effectiveness of preoperative 
celecoxib for postoperative pain management after a total knee arthroplasty (TKA).  
Rofecoxib had previously been studied in coxib studies, but in September 2004, it was 
withdrawn from the market due to its thromboembolic effects, particularly myocardial 
infarction.9  
 This study showed that a preemptive dose of oral celecoxib can be used to achieve 
less postoperative pain and better rehabilitation after TKA surgery, especially in the first 
week.  Although there have been previous studies which have evaluated the analgesic 
efficacy of rofecoxib, few studies have evaluated the efficacy of celecoxib for TKA.  This 
study hypothesized that celecoxib provides better efficacy than the use of patient-
controlled analgesic (PCA) morphine, which is currently the standard therapy.  Huang et 
al9 aimed to compare the difference in the pain scores at rest, pain during ambulation, 
range of motion (ROM) and morphine-sparing effects of celecoxib.9 
 In this study all TKA surgeries were performed by one surgeon (Ching-Chuan 
Jiang). This study was a randomized, prospective, observer-blind study design.  Subjects 
were sorted by random numbers into two groups.  This study used the diagnosis of 
primary osteoarthritis and  over the age of sixty as it inclusion criteria.  Exclusion criteria 
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for this study were the diagnosis of rheumatoid arthritis, end-stage renal disease, previous 
cerebral vascular accident history, history of  peptic ulcers, recent myocardial infarction 
(within 1 year), and allergy to sulfa, NSAIDs, or morphine.9  
 According to the study, group A (n = 40) received 400 mg oral celecoxib at about 1 
hour prior to surgery, and 200 mg every 12 hours, along with PCA morphine, over the 
first five post-operative days.  Group B (n = 40) received only the PCA morphine over 
the same postoperative period.9 
 The celecoxib group had lower postoperative VAS pain at rest than group B at 48 
hours (p = 0.03) and 72 hours (p = 0.02) after TKA surgery.  Group A had reduced 
postoperative pain at ambulation, but did not reach significant difference when compared 
with group B.  Repeated measures showed that the celecoxib group had significant VAS 
pain score reduction when compared to the control group at rest (p = 0.023) but not 
during ambulation (p = 0.51).9 
 The study report that celecoxib significantly improved postoperative knee ROM, 
especially during the first three days (Day1: p = 0.01; Day 2: p = 0.004; Day 3: p = 
0.004).  This group also had increased active ROM of 12–16 degrees in comparison with 
the control group.  Repeated measures showed that the celecoxib group also had 
significantly better postoperative ROM than the control group (p = 0.0009).9  
 PCA morphine usage was notably lower in group A.  PCA usage during the first 24 
hours was significantly lower (15.1 ± 8.7 mg vs 19.7 ± 9.6 mg; p = 0.03).  Norman et al9 
reported that the total PCA morphine usages in the celecoxib group and controls were 
17.6 ± 11.9 and 24.6 ± 14.6 mg, respectively (p = 0.03). The celecoxib group used about 
40% less morphine.9 
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DI SC USSI ON 
 In Takada et al,6 2007, Norman et al7 and  Takada et al,8 2009, which were double 
blinded studies, it was found that the VAS scores were significantly lower during the first 
four to six hours post surgery.  While the VAS scores were down in all the studies, opioid 
sparing was found to only be significant in two 6,7 out of the three studies.6,7,8 and it was 
only significant for two to four hours.  The Huang et al9 study was only blinded to the 
observer and did not have a placebo group and it continued NSAID usage after surgery.  
However it did have more pain relief and greater opioid sparing than the other studies 
reviewed.  
 Moreover, the Takada et al,6 2007, Norman et al7 and Takada et al,8 2009, studies 
where very thoroughly done (Table 1) and even though the Huang et al9 study could have 
had a lot of biases, it still made very valid observations that the other three studies 
ignored. Takada et al,6 2007, Norman et al7 and  Takada et al,8 2009, studies were double 
blind with placebos given to reduce the prejudice in the study.  The Huang et al9 study 
used was different in that it was only blinded to the observer.  The way this study was 
conducted left it open to possible bias but it does make several observation not included 
in the other studies.   
 The biggest omission from all the studies 6-9 was a record of the instructions that 
were given to patients on the usage of PCA pumps and when the patient should take other 
postoperative analgesics.  It is often explained to patients that they should stay on top of 
their pain by pushing the PCA button every 15 minutes or so before they feel the pain.  
These instructions are to help patients not reach a hyperalgesic state.  The instructions for 
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postoperative analgesics could easily skew the amount of  analgesics used after surgery, 
and could explain why, in many of the studies, little to no difference in the amount of 
pain medication used to control postoperative pain was found, whereas VAS scores 
remained lower in experimental groups.  Another omission from Norman et al was 
followup on all the patients instead of just dropping them out of a study because exact 
protocol was not followed.   
 One of the focuses of the observational study by Haung et al,9 although it could of 
had the most bias, was that all the surgeries performed by one surgeon, Ching-Chuan 
Jiang.  The Huang et al9 study, unlike the other studies, eliminated the variable of 
different surgeons’ techniques.  This study also continued the use of NSAIDS after 
surgery to further decrease opioid usage and increase pain control.  It was also the only 
study that used a COX-2 that is approved by the FDA.  Finally, it also looked at 
improved range of motion and had a study length of one week post surgery, making it the 
longest study by several days. 
 In the Takada et al,6 2007, and Norman et al7 studies the surgeries were done with 
cuffs to reduce bleeding.  The fact that these surgeries were performed while using an 
inflated cuff also helped decrease bias of pain killers taking too long a time to get to the 
site post surgery.  The control groups were given analgesics shortly after the cuff was 
inflated which would ensure the immediate delivery of analgesics when the cuff was 
deflated. 
 PGE2 plasma concentrations were also found to be decreased in the experimental 
group in the Takada et al,6 2007, study.  This helped validate the lower VAS scores, 
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which are subjective, that were reported in the experimental group by using a blood test, 
which is objective.  
 
C ONC L USI ON 
 Non-steroidal anti-inflammatory drugs have been shown to have a greater 
postoperative effect on pain relief when given preemptively to those undergoing 
orthopedic surgery, than currently used postoperative practices.  Opioid sparing is 
possible with preemptive use of NSAIDs, but where they to be used every 12 hours after 
surgery further opioid sparing could be possible as discussed in the Haung et al6 study.  
Future studies, examining the use of NSAIDs preemptively in orthopedic surgery, should 
be to relieve postoperative pain and increase opioid spearing should be double blind 
prospective study, uses a 100-mm VAS scale, a single surgeon, using the NSAIDs post 
operatively, make sure placebo and control solution look the same, making sure to 
explain when and how to use postoperative analgesics, take care to look at the overall 
total of opioid usage over longer period of time and the measuring plasma concentration 
of PGE2.  It is also important to follow up and analyze all patients in there assigned 
group.  Future studies observing preemptive NSAID use verses of opioid use in patients 
need to be completed carefully as each drug does have its own adverse effects.  These 
studies do need to be done so physicians can, when possible, treat patients with fewer 
opioids and help minimize the problems with addiction and dependency.   
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T able 1 Summary Matrix 
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Study Y r .  
publis
hed 
Patients/  
Population 
I nter vention C ompar
ison 
Outcome(s) Study 
type 
V alidit
y 
(J adad 
scor e) 
C omments 
Takada 
et al 
2007 32 ASA 
physical status 
I-II patients 
scheduled for 
total knee 
arthroplasty or 
open anterior 
cruciate 
Flubuprofrin 
one mg/kg IV 
6min before 
surgery 
Placebo VAS scores 
and 
consumptio
n of 
Buprenorph
ine was 
lower in 
intervention 
group and 
also PGE2 
showed no 
increase.  
The placebo 
group  
Rando
mized 
double 
blind 
controll
ed 
study 
4 lost 
point 
for 
rando
mizati
on by 
sealed 
envelo
pe 
They measured the 
PGE2 which stimulates 
neurons directly.  
Norman 
et al 
2001 54 Adults with 
ankle fractures 
having open 
orthopedic 
surgery 
Ketoralac 30 
mg IV 16min 
before surgery  
Placebo VAS scores 
were down 
in 
intervention 
group, 
opioid use 
was the 
same, blood 
loss was the 
same 
Rando
mized 
double 
blind 
controll
ed 
study 
5 This was a well done 
randomized trial 
presentation of results. 
Could be better.  
Although the Ketoralac 
group had less pain 
initially but used about 
the same opioids as 
placebo group.   
Takada 
et al 
2009 44 patients 
undergoing 
elective  
flubuprofrin 
one mg/kg IV 
6min before 
surgery 
Placebo Opioid use, 
Vas scores 
where all 
down 
Rando
mized 
double 
blind 
controll
ed 
study 
3 Here it was able to show 
decrease in opioids but 
there discussion is week 
and used randomly 
quotes from other studies 
some of which did not 
pertain. 
Huang 
et al 
2008 80 patients 
underwent 
total knee 
arthroplasty  
400 mg dose 
clecoxib, one 
hour before 
surgery, and 
2oomg 
celecoxib 
every 12 hours 
for five days 
control 
group 
no 
placebo 
Postoperativ
e pain at 
rest 48h and 
72 hours out 
and opioid 
consumptio
n was 
decreased 
Rando
mized 
observe
r blind 
control 
study 
3 This study was not very 
well done although it 
still scored a Jadad score 
of three mainly just 
cause it was randomized.  
There is a lot of chances 
for bias to enter this 
paper and some of its 
references where taken 
out of context.  
I.  
 
 
 
 
T able 2 Plasma concentration of PGE2 Takada et al, 20076 
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 T1 T2 T3 
Group A    
Cubital pg/mL 212 ± 82 237 ± 82 258 ± 103 
Femoral pg/mL 211 ± 61 359 ± 105abc 252 ± 77 
Group B    
Cubital pg/mL 176 ± 39 191 ± 49 206 ± 61 
Femoral pg/mL 201 ± 49 237 ± 63 239 ± 85 
Data are presented as means ± SD 
 a P < .01 vs T1 
 b P < .01 vs group B (at T2) 
 c P < .o1 vs cubital vein (at T2) 
 
 
T able 3 Postoperative pain Takada et al, 20098 
Postoperative Time (hours)  
 0.5 1 2 4 6 12 24 
Group A 70(30-100) 60(40-100) 60(20-80) 50(10-90) 38(20-80) 30(0-90) 30(0-80) 
Group B 35(0-70) 25(0-70) 15(0-70) 12(0-70) 20(0-70) 25(0-80) 30(0-75) 
P Value <.0001* <.0001* <.0001* <.0001* <.0008* 0.4146 0.9528 
*P< .01 was regarded as significant 
Data are presented as median ranges 
 
 
T able 4 Analgesic Consumption Takada et al, 20098 
Postoperative time (hour) 
 Within 2 2-6 6-24 
Group A (mg) 0.1 (0-0.2) 0 (0-0.1) 0 (0-0.1) 
Group B (mg) 0 (0-0.1) 0 (0-0.1) 0.1 (0-0.2) 
P value .0002* 0.2216 0.2865 
*P< 0.01 was regarded as significant 
Data are presented as median ranges 
 
 
